1
|
Rosiello G, Re C, Cei F, Basile G, Musso G, Fallara G, Belladelli F, Cignoli D, Canibus D, Soares Pinto S, Necchi A, Marandino L, Karakiewicz P, Rowe I, Villa G, Boarin M, Disabato N, Trevisani F, Bettiga A, Briganti A, Montorsi F, Salonia A, Larcher A, Capitanio U. Frailty Index in predicting surgical outcomes after partial nephrectomy in patients with renal cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00892-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
2
|
Re C, Belladelli F, Cei F, Nazario T, Basile G, Musso G, Fallara G, Rosiello G, Matloob R, Moschini M, Cignoli D, Canibus D, Karakiewicz P, Rowe I, Lucianò R, Doglioni C, Colecchia M, Bertini R, Briganti A, Montorsi F, Salonia A, Larcher A, Capitanio U. Lymphovascular invasion predicts lymph node involvement in patients with renal cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00504-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
3
|
Baiamonte G, Rosiello G, Cei F, Tenace N, Musso G, Basile G, Re C, Fallara G, Belladelli F, Cignoli D, Colecchia M, Rowe I, De Cobelli F, Pennella R, Della Corte A, Brembilla G, Bertini R, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Lucianò R, Capitanio U. The current role of renal tumor biopsy in the management of small renal masses: Long-term results from a prospective, single-institutional database. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01315-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
4
|
Rosiello G, Baiamonte G, Basile G, Fallara G, Re C, Musso G, Cei F, Cignoli D, Avesani G, Disabato N, Villa G, Boarin M, Canibus D, Karakiewicz P, Dehò F, Suardi N, Briganti A, Salonia A, Montorsi F, Larcher A, Capitanio U. Lawton instrumental activities of daily living scale identifies patients at high-risk of adverse outcomes after kidney surgery for renal cancer: A prospective clinical study. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00897-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
5
|
Fallara G, Martini A, Rosiello G, Belladelli F, Musso G, Cei F, Basile G, Re C, Cignoli D, De Cobelli F, Brembilla G, Marandino L, Raggi D, Gandaglia G, Mazzone E, Moschini M, Stabile A, Briganti A, Necchi A, Montorsi F, Salonia A, Larcher A, Capitanio U. Defining the most useful intermediate endpoint for overall survival in intermediate and high-risk clear cell carcinoma. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00517-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
6
|
Belladelli F, Re C, Cei F, Musso G, Fallara G, Basile G, Rosiello G, Cignoli D, Canibus D, Bertini A, Bertini R, Lucianò R, Tenace N, Necchi A, Raggi D, Marandino L, Montorsi F, Salonia A, Briganti A, Guazzarotti G, Brembilla G, De Cobelli F, Capitanio U, Larcher A. Clinical benefit and cost-effectiveness of a biopsy-all strategy in patients diagnosed with renal mass: Simulation of a randomized controlled trial. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)01314-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
7
|
Musso G, Basile G, Nini A, Rosiello G, Fallara G, Re C, Cei F, Belladelli F, Cignoli D, Canibus D, Soares Pinto S, Rowe I, Lucianò R, Tenace N, Salonia A, Briganti A, Matloob R, Bertini R, Necchi A, Marandino L, Raggi D, Montorsi F, Larcher A, Capitanio U. Venous tumour thrombus in renal cell carcinoma: Locally advanced or metastatic disease? Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00380-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
8
|
Cei F, Tenace N, Basile G, Musso G, Re C, Fallara G, Rosiello G, Belladelli F, Cignoli D, Canibus D, Rowe I, De Cobelli F, Brembilla G, Pennella R, Della Corte A, Guazzarotti G, Bertini R, Briganti A, Colecchia M, Montorsi F, Salonia A, Larcher A, Lucianò R, Capitanio U. Concordance of renal sinus or calyces invasion between preoperative imaging and final pathology after surgery for kidney cancer. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00511-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
9
|
Re C, Rosiello G, Fallara G, Basile G, Cignoli D, Martini A, De Cobelli F, Brembilla G, Nocera L, Belladelli F, Colandrea G, Canibus D, Musso G, Cei F, Matloob R, Briganti A, Bertini R, Necchi A, Raggi D, Karakiewicz P, Montorsi F, Salonia A, Larcher A, Capitanio U. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01256-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
10
|
Belladelli F, Larcher A, Ieva A, Rowe I, Fallara G, Cignoli D, Colandrea G, Santangelo M, Lucianò R, Doglioni C, Clerici S, Castellino L, Damascelli A, Guazzarotti G, De Cobelli F, Bertini R, Montorsi F, Capitanio U, Salonia A. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel Lindau renal cell carcinoma. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01258-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
11
|
Capogrosso P, Ventimiglia E, Fallara G, Costa A, De Angelis M, Colandrea G, Belladelli F, Pellegrino F, Candela L, Pozzi E, Cignoli D, Schifano N, Cazzaniga W, Matloob R, Dehò F, Scattoni V, Salonia A, Montorsi F. Prostate volume is associated with optimal “trifecta” outcomes after holep – results from a prospective trial (EXPHO). EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01064-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
12
|
Basile G, Rosiello G, Fallara G, Colandrea G, Cignoli D, Musso G, Cei F, Re C, Ieva A, Canibus D, Rigatti P, Guazzoni G, Dehò F, Gallina A, Karakiewicz P, Mottrie A, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U, Larcher A. The learning curve of radical nephrectomy for kidney cancer: implications for surgical training. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01191-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
13
|
Fallara G, Rosiello G, Necchi A, Raggi D, Cazzaniga W, Martini A, Basile G, Cignoli D, Colandrea G, Baiamonte G, Belladelli F, Musso G, Cei F, Giancristofaro C, Ieva A, Canibus D, Briganti A, Bertini R, Montorsi F, Salonia A, Larcher A, Capitanio U. Oncologic outcomes in patients diagnosed with PT3A non-metastatic renal cell cancer according to renal vein thrombus or fat invasion. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01257-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
14
|
Fallara G, Tutolo M, Specchio V, Giraudo D, Mathur SG, Costa A, Pellegrino F, Beladelli F, De Angelis M, Cignoli D, Colandrea G, Capogrosso P, Ventimiglia E, Salonia A, Montorsi F. Patients adhering to standardized protocols for pelvic floor muslce training after holep show higher rates of postoperative incontinence: real-life implications for a rational management work-up. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01270-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
15
|
Musso G, Rosiello G, Fallara G, Cignoli D, Basile G, Colandrea G, Cei F, Baiamonte G, Belladelli F, Giancristofaro C, Canibus D, Rowe I, Karakiewicz P, Briganti A, Bertini R, Montorsi F, Salonia A, Larcher A, Capitanio U. Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01262-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
16
|
Colandrea G, Larcher A, Cignoli D, Fallara G, Rosiello G, Basile G, Baiamonte G, Cei F, Musso G, Canibus D, Bertini R, Karakiewicz P, Mottrie A, Dehò F, Gallina A, Montorsi F, Salonia A, Capitanio U. Risks and benefits of partial nephrectomy with limited or without ischemia time. EUR UROL SUPPL 2022. [DOI: 10.1016/s2666-1683(22)01260-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Fallara G, Boeri L, Candela L, Costa A, Capogrosso P, Cazzaniga W, Schifano N, Pozzi E, Belladelli F, Cignoli D, Colandrea G, Cornelius J, Mattei A, Montorsi F, Salonia A. Impact of urinary incontinence on sexual function in patients presenting for lower urinary tract symptoms. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
18
|
Boeri L, Capogrosso P, Cazzaniga W, Candela L, Fallara G, Pozzi E, Belladelli F, Schifano N, Cignoli D, Colandrea G, Massimiliano R, Abbate C, Montorsi F, Salonia A. Prevalence and predictors of unrecognized low sexual desire in men with new onset erectile dysfunction – findings from a cross-sectional, real-life study. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
19
|
Fallara G, Capogrosso P, Boeri L, Cazzaniga W, Candela L, Schifano N, Costa A, Pozzi E, Belladelli F, Cignoli D, Raffo M, Matloob R, Cornelius J, Ventimiglia E, Mattei A, Montorsi F, Salonia A. Peyronie's disease in young adults: Symptomatic burden and clinical characteristics. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Boeri L, Capogrosso P, Cazzaniga W, Candela L, Fallara G, Pozzi E, Belladelli F, Schifano N, Cignoli D, Colandrea G, Abbate C, Montorsi F, Salonia A. Hyperestrogenism is associated with sexual function impairment in men – findings from a cross-sectional, real-life study. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Pozzi E, Fallara G, Candela L, Costa A, Boeri L, Capogrosso P, Schifano N, Cignoli D, Colandrea G, Raffo M, Cornelius J, Mattei A, Montorsi F, Salonia A. Primary organic vs. primary psychogenic erectile dysfunction: a cross-sectional study on patient's characteristics and sexual function from a tertiary referral center. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
22
|
Capogrosso P, Candela L, Costa A, Cazzaniga W, Fallara G, Cignoli D, Boeri L, Colandrea G, Schifano N, Cornelius J, Abbate C, Dehò F, Mattei A, Montorsi F, Salonia A. Selecting patients for penile doppler ultrasound in clinical practice. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Capogrosso P, Candela L, Cazzaniga W, Costa A, Fallara G, Boeri L, Pozzi E, Belladelli F, Schifano N, Cignoli D, Dehò F, Abbate C, Montorsi F, Salonia A. Are patients really willing to undergo surgery for Peyronie's disease? J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
24
|
Fallara G, Pozzi E, Belladelli F, Corsini C, Raffo M, Candela L, Costa A, Cignoli D, Schifano N, D'Arma A, Capogrosso P, Boeri L, Cazzaniga W, Matloob R, Mirone V, Dehó F, Montorsi F, Salonia A. Relevance of self-masturbation-related vs. coital erectile function in the real-life management of patients with erectile dysfunction. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00617-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
25
|
Larcher A, Cignoli D, Fallara G, Rosiello G, Basile G, Colandrea G, Baiamonte G, Cei F, Musso G, Canibus D, Bertini R, Karakiewicz P, Mottrie A, Dehó F, Gallina A, Montorsi F, Salonia A, Capitanio U. Risks and benefits of partial nephrectomy with limited or without ischemia time. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00429-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
Larcher A, Belladelli F, Ieva A, Rowe I, Fallara G, Cignoli D, Colandrea G, Santangelo M, Lucianò R, Doglioni C, Clerici S, Castellino L, Damascelli A, Guazzarotti G, De Cobelli F, Bertini R, Montorsi F, Capitanio U, Salonia A. Systematic definition of treatment modality and clinical outcomes reporting system in case of surgical treatment for Von Hippel-Lindau renal cell carcinoma. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00310-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Fallara G, Rosiello G, Raggi D, Marandino L, Malena G, Basile G, Colandrea G, Cignoli D, Belladelli F, Musso G, Cei F, Bertini R, Briganti A, Salonia A, Montorsi F, Larcher A, Necchi A, Capitanio U. Application of the KEYNOTE-564 trial results to real life population: Which patients with advanced kidney cancer should receive adjuvant pembrolizumab. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01079-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Rosiello G, Cei F, Fallara G, Cignoli D, Basile G, Colandrea G, Musso G, Baiamonte G, Belladelli F, Giancristofaro C, Canibus D, Rowe I, Trevisani F, Bettiga A, Briganti A, Bertini R, Montorsi F, Salonia A, Larcher A, Capitanio U. Assessing the effect of red blood cell transfusion on the risk of acute kidney injury after nephron-sparing surgery. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00222-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
29
|
Rosiello G, Fallara G, Basile G, Cignoli D, De Cobelli F, Brambilla G, Nocera L, Belladelli F, Colandrea G, Canibus D, Re C, Musso G, Cei F, Giancristofaro C, Briganti A, Bertini R, Necchi A, Raggi D, Mottrie A, Karakiewicz P, Montorsi F, Salonia A, Larcher A, Capitanio U. The anatomical location of lymphadenopathies at imaging predicts the risk of lymph node invasion at final pathology in patients with renal cell carcinoma. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01068-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
30
|
Capogrosso P, Ventimiglia E, Fallara G, Costa A, De Angelis M, Colandrea G, Belladelli F, Pellegrino F, Candela L, Pozzi E, Cignoli D, Schifano N, Cazzaniga W, Matloob R, Dehò F, Scattoni V, Salonia A, Montorsi F. Prostate volume is associated with optimal TRIFECTA outcomes after HoLEP – results from a prospective trial (ExpHo). Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00950-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
31
|
Belladelli F, Fallara G, Pozzi E, Corsini C, Raffo M, Candela L, Costa A, Cignoli D, Schifano N, D'Arma A, Capogrosso P, Boeri L, Ventimiglia E, Matloob R, Pagliardini L, Montorsi F, Salonia A. The effect of historical CMV infection on sperm parameters in white-European infertile men: Findings from a real-life cross-sectional study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00885-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
Capogrosso P, Ventimiglia E, Fallara G, Costa A, Pellegrino F, Candela L, Pozzi E, Belladelli F, De Angelis M, Colandrea G, Cazzaniga W, Cignoli D, Schifano N, Matloob R, Degò F, Scattoni V, Salonia A, Montorsi F. Risk of orgasmic function impairment after HoLEP – findings of a prospective real-life trial (ExpHo). Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00626-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
33
|
Boeri L, Pozzi E, Belladelli F, Fallara G, Raffo M, Corsini C, Candela L, Costa A, Cignoli D, Schifano N, D'Arma A, Ventimiglia E, Capogrosso P, Dehó F, Mirone V, Pagliardini L, Papaleo E, Montorsi F, Salonia A. The impact of different WHO reference criteria for semen analysis in clinical practice: Who will benefit from the new 2021 cutoffs for normal sperm parameters? Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00886-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
34
|
Rosiello G, Baiamonte G, Fallara G, Basile G, Luciano R, Colecchia M, Martini A, Cignoli D, Nocera L, Belladelli F, Colandrea G, Canibus D, Re C, Musso G, Cei F, Briganti A, Bertini R, Necchi A, Raggi D, Karakiewicz P, Montorsi F, Salonia A, Larcher A, Capitanio U. The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00136-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Boeri L, Belladelli F, Pozzi E, Fallara G, Raffo M, Corsini C, Candela L, Costa A, Cignoli D, Schifano N, D'Arma A, Capogrosso P, Ventimiglia E, Pagliardini L, Papaleo E, Mirone V, Dehó F, Montorsi F, Salonia A. Low birth weight is associated with sperm dna fragmentation and assisted reproductive technology outcomes in primary infertile men – results of a cross-sectional study. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00889-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Fallara G, Boeri L, Candela L, Costa A, Capogrosso P, Belladelli F, Pozzi E, Raffo M, Corsini C, Cignoli D, Schifano N, Cazzaniga W, Colandrea G, D'Arma A, Matloob R, Mirone V, Montorsi F, Salonia A. Impact of urinary incontinence on sexual function in patients presenting for lower urinary tract symptoms. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00914-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Rosiello G, Fallara G, Basile G, Martini A, Cignoli D, Nocera L, Belladelli F, Colandrea G, Canibus D, Re C, Musso G, Cei F, Giancristofaro C, Briganti A, Bertini R, Necchi A, Raggi D, Karakiewicz P, Montorsi F, Salonia A, Larcher A, Capitanio U. The detrimental effect of frailty status on renal function recovery after partial nephrectomy – long-term results from a prospective surgical cohort. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00292-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
Schifano N, Capogrosso P, Fallara G, Pozzi E, Belladelli F, Candela L, Corsini C, Raffo M, Costa A, Cignoli D, D'Arma A, Boeri L, Ventimiglia E, Matloob R, Mirone V, Deho' F, Montorsi F, Salonia A. Predictors of phosphodiesterase type 5 Inhibitors (PDE5I)-discontinuation – Is a previous PDE5I-exposure at first clinical evaluation related with a higher PDE5I-drop-out risk? Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)00619-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
39
|
Capogrosso P, Ventimiglia E, Costa A, Pellegrino F, Candela L, Cazzaniga W, Cignoli D, Schifano N, Fallara G, Matloob R, Dehò F, Scattoni V, Salonia A, Montorsi F. Unfavourable outcomes after holmium laser enucleation of the prostate (HoLEP) are common also in the hands of a very esperienced surgeon – results from a prospective trial (ExpHo). EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00801-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
40
|
Rosiello G, Fallara G, Martini A, Cignoli D, Basile G, Colandrea G, Baiamonte G, Canibus D, Trevisani F, Bettiga A, Tian Z, Kapoor A, Shariat S, Giancristofaro C, Romani M, Briganti A, Montorsi F, Salonia A, Karakiewicz P, Larcher A, Capitanio U. Partial nephrectomy in frail patients: effect of surgical approach on complications and health-careexpenditures. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00758-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
41
|
Capogrosso P, Candela L, Cazzaniga W, Costa A, Fallara G, Boeri L, Pozzi E, Belladelli F, Schifano N, Cignoli D, Costantino A, Montosi F, Salonia A. Are patients really willing to undergo surgery for Peyronie’s disease? EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00726-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
42
|
Colandrea G, Cignoli D, Basile G, Fallara G, Rosiello G, Musso G, Cei F, Giancristofaro C, Romani M, Canibus D, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U, Larcher A. Is whenever feasible-strategy for partial nephrectomy invariably justified? The impact of tumour clinical size on postoperative renal function. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00757-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
43
|
Ventimiglia E, Capogrosso P, Costa A, Pellegrino F, Candela L, Fallara G, Cazzaniga W, Cignoli D, Schifano N, Matloob R, Dehò F, Scattoni V, Salonia A, Montorsi F. What results should you expect from holmium laser enucleation of the prostate after completing the surgeon’s learning curve? benchmark results from an experienced single surgeon series of patients with large prostate. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)00800-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
44
|
Ventimiglia E, Boeri L, Pozzi E, Belladelli F, Fallara G, Candela L, Capogrosso P, Schifano N, Cignoli D, Colandrea G, Cornelius J, Mattei A, Abbate C, Montorsi F, Salonia A. P–089 Paternal age affects the performance of EAU guidelines for genetic testing in infertile men: implications for candidate selection. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
We aimed at challenge EAU Guidelines for genetic testing performance in infertile men according to normal vs. advanced paternal age (APA).
Summary answer
EAU Guidelines perform better in karyotype analysis (KA) and Y-chromosome microdeletions (YCM) investigation in men above 35 years of age.
What is known already
EAU Guidelines for genetic testing in infertile men recommend specific threshold for candidate selection for both KA (<10 million spermatozoa/ml) and YCM (<5 million spermatozoa/ml). However, paternal age is not taken into account for candidate selection in this setting.
Study design, size, duration
Data from 2188 infertile men (according to WHO definition) consecutively evaluated at a single academic centre were analysed.
Participants/materials, setting, methods
Demographic, clinical and laboratory data were analysed. Semen analyses were based on 2010 WHO criteria. Advanced age was defined as above 35. All men underwent KA and YCM testing. EAU Guidelines were validated in our cohort and according to APA. Specificity, sensitivity, and AUC were estimated for all scenarios. A Wald-type test compared AUC according to APA for KA and YCM. Decision curve analysis (DCA) estimated the benefit of using EAU Guidelines according to APA.
Main results and the role of chance
Median (IQR) paternal age was 37 (34–41) years. Advanced paternal age was found in 1306 (60%) of included men. Prevalence of KA and YCM was 4% (48 men) and 1% (13 men), respectively. EAU Guidelines sensitivity, specificity and AUC in the overall population were 85%, 47% and 66% for KA, whereas they were 100%, 57% and 80% for YCM. When stratifying according to APA, EAU Guidelines performed better in men over 35 both in terms of KA and YCM detection. Specifically, AUC for KA detection in men with APA was 70% vs. 63% in younger men (p = 0.04). AUC for YCM detection in men with APA was 82% vs. 79% in younger men (p = 0.03). DCA confirmed higher net benefit in using EAU Guidelines in old vs. young men for the detection of both KA and YCM.
Limitations, reasons for caution
It is a retrospective analysis at a single, tertiary-referral academic centre, thus raising the possibility of selection biases.
Wider implications of the findings: EAU Guidelines for genetic testing in infertile men perform differentially according to APA. KA and YCM are better detected in older men, likely due to a wider pool of confounding etiological factors in young men. These results suggest the implementation of more accurate predictive models in younger men.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- E Ventimiglia
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - L Boeri
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - E Pozzi
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - F Belladelli
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - G Fallara
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - L Candela
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - P Capogrosso
- ASST Sette Laghi – Circolo e Fondazione Macchi Hospital, Unit of Urology, Varese, Italy
| | - N Schifano
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - D Cignoli
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - G Colandrea
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - J Cornelius
- Luzerner Kantonsspital, Unit of Urology, Lucerne, Switzerland
| | - A Mattei
- Luzerner Kantonsspital, Unit of Urology, Lucerne, Switzerland
| | - C Abbate
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - F Montorsi
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| | - A Salonia
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI, Milan, Italy
| |
Collapse
|
45
|
Boeri L, Candela L, Pozzi E, Belladelli F, Capogrosso P, Cazzaniga W, Costa A, Fallara G, Schifano N, Cignoli D, Ventimiglia E, Alfano M, Abbate C, Montorsi F, Salonia A. O-151 Detailed characterization of infertile men with idiopathic versus unexplained infertility: a single-center experience. Hum Reprod 2021. [DOI: 10.1093/humrep/deab127.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
We aimed to investigate the rate of and the clinical characteristics of men with idiopathic versus unexplained infertility from a cohort of white-European men.
Summary answer
Approximately 20% and 5% of men evaluated for primary couple’s infertility depicted characteristics suggestive for idiopathic and unexplained infertility, respectively.
What is known already
Male factor infertility (MFI) can be associated with clinical, hormonal and genetic diseases, but MFI is idiopathic in almost 30% of cases.
Study design, size, duration
Data from 3098 infertile men (according to WHO definition) consecutively evaluated between 2003-2020 at a single academic centre were analysed and compared with those of 103 fertile controls. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Idiopathic infertility was defined for pathological semen analysis but normal physical examination and endocrine, genetic and biochemical laboratory testing. Unexplained infertility is defined as infertility of unknown origin with normal sperm parameters.
Participants/materials, setting, methods
Testicular volume (TV) was assessed with a Prader’s orchidometer. Serum hormones and sperm DNA fragmentation index (SDF) were measured in every patient. Vitamin D3 (VitD) deficiency was considered for vitD levels <20 ng/mL. Semen analyses were based on the 2010 WHO reference criteria. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI).
Main results and the role of chance
Overall, 570 (18.5%) and 154 (5.0%) patients depicted criteria suggestive for either idiopathic or unexplained primary infertility, respectively. Groups were similar in terms of age, BMI, CCI, recreational habits, circulating serum hormones and SDF. Testicular volume was lower in men with idiopathic vs. unexplained infertility [median (IQR) 20 (15-25) vs. 20 (17-25); p < 0.001]; more idiopathic than unexplained infertile men depicted TV < 15ml (23.4% vs. 12%; p < 0.01). Similarly, vitD levels were lower [22 (17-28) vs. 27 (21-42) ng/mL; p < 0.001] in idiopathic vs. unexplained infertile men, with a higher rate of pathologic VitD levels in the same group (42.1% vs. 10%; p = 0.04). When compared to fertile controls, groups were similar in terms of age, BMI, CCI and serum hormones values. TV was larger in fertile controls than idiopathic and unexplained infertile men (all p < 0.01). At multivariable logistic regression analysis only vitD deficiency (OR 8.1, p = 0.03) was found to be associated with idiopathic infertility after accounting for age, BMI, testosterone values and TV.
Limitations, reasons for caution
The small number of fertile controls may raise the possibility of biases.
Wider implications of the findings
Idiopathic and unexplained infertility were identified in approximately 20% and 5% of men evaluated, respectively. Idiopathic infertile men showed lower TV and lower vitD values compared to men with unexplained infertility. Future studies are needed to develop a more tailored management to these difficult MFI cases.
Trial registration number
.
Collapse
Affiliation(s)
- L Boeri
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - L Candela
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - E Pozzi
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - F Belladelli
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - P Capogrosso
- Ospedale di Circolo and Macchi Foundation- Varese., Department of Urology and Andrology, Varese, Italy
| | - W Cazzaniga
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - A Costa
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - G Fallara
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - N Schifano
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - D Cignoli
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - E Ventimiglia
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - M Alfano
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - C Abbate
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - F Montorsi
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| | - A Salonia
- Università Vita-Salute San Raffaele, Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele- Milan- Italy- University Vita-Salute San Raffaele- Milan- Italy., Milan, Italy
| |
Collapse
|
46
|
Boeri L, Capogrosso P, Pozzi E, Candela L, Belladelli F, Cazzaniga W, Fallara G, Cignoli D, Schifano N, Ventimiglia E, Alfano M, Colandrea G, Abbate C, Montorsi F, Salonia A. P–108 Which infertile men with normal semen analysis deserve a second semen analysis in the real-life setting? Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Guidelines suggest that one semen analysis is sufficient during the diagnostic work-up of an infertile man in the case of normality as for WHO criteria.
Summary answer
We investigated the rate and the clinical features of men with abnormal sperm parameters at a second test, after a normal first semen analysis.
What is known already
A second test is recommended when the first semen analysis depicted abnormal sperm parameters.
Study design, size, duration
Complete demographic, clinical and laboratory data from 1358 consecutive primary infertile men (infertility as for WHO definition) were analysed. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Serum hormones were measured in every patient. Patients underwent two consecutive semen analyses at the same laboratory, which followed 2010 WHO reference criteria.
Participants/materials, setting, methods
Descriptive statistics and logistic regression models tested the association between clinical variables and semen parameters. Receiver operative characteristic (ROC) curves were used to assess the relationship between clinical variables and to create a composite risk score for pathological sperm parameters at a second test.
Main results and the role of chance
At first analysis, 212 (15.6%) infertile men had normal semen parameters. Of 212, 87 (41.0%) had a second normal semen analysis, while 80 (37.7%), 35 (16.5%) and 10 (4.7%) men showed 1, 2 and 3 pathological sperm parameters at second test. Men with a pathological second semen analysis had higher CCI scores (p < 0.001), smaller testicular volume (p < 0.001) and higher FSH values (p < 0.01) than those with normal second samples. Overall, despite being within normal ranges, sperm concentration was lower [34 (23–57) vs. 62 (35–94); p < 0.01] in men with an abnormal second sample compared to those with confirmed normality. At multivariable logistic regression analysis, smaller testicular volume (OR 0.9, p = 0.03), FSH (OR 1.2, p < 0.01), and lower sperm concentration (OR 0.9, p < 0.01) were associated with pathological second semen analyses, after accounting for age and CCI. ROC curves showed that testicular volume <15 ml, FSH values >6 mUI/ml and sperm concentration <40 mil/ml had good predictive ability for pathologic second sperm parameters (all AUC >0.8). Considering 1-point for each of the previous variables, the chances of a pathological second analysis increased from 38.8% to 74.6%, 77.3% and 100% among patients with risk scores of 0, 1, 2 and 3, respectively (p < 0.001).
Limitations, reasons for caution
It is a retrospective analysis at a single, tertiary-referral academic centre, thus raising the possibility of selection biases. In spite of this, all patients have been consistently analysed over time with a rigorous follow-up, thus limiting potential heterogeneity in terms of data reporting.
Wider implications of the findings: Approximately 60% of infertile men with a normal semen analysis depicted a pathological second test. Smaller testicles, higher FSH, lower sperm concentrations were independently associated with a pathologic second test. These features could be useful to identify those infertile men with a normal semen analysis who deserve a second test.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- L Boeri
- UOC Urologia Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico- Dipartimento di Scienze Cliniche e di Comunità- Università degli Studi di Milano, Urology, Milan, Italy
| | - P Capogrosso
- ASST Sette Laghi – Circolo e Fondazione Macchi Hospital, Urology, Varese, Italy
| | - E Pozzi
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - L Candela
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - F Belladelli
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - W Cazzaniga
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - G Fallara
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - D Cignoli
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - N Schifano
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - E Ventimiglia
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - M Alfano
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - G Colandrea
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - C Abbate
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - F Montorsi
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| | - A Salonia
- Università Vita-Salute San Raffaele- Division of Experimental Oncology/Unit of Urology- URI- IRCCS Ospedale San Raffaele, Urology, Milan, Italy
| |
Collapse
|
47
|
Fallara G, Boeri L, Candela L, Pozzi E, Belladelli F, Capogrosso P, Cazzaniga W, Ventimiglia E, Schifano N, Costa A, Cignoli D, Cornelius J, Mattei A, Montorsi F, Salonia A. P–094 Kidney function impairment in primary infertile men. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
We investigated the prevalence of kidney function impairment in a homogeneous cohort of white-European primary infertile men.
Summary answer
Mild kidney function impairment characteristics were found in 9% of asymptomatic and unaware patients presenting for primary infertility investigation.
What is known already
Infertile men have shown a worse overall health status compared to the fertile counterpart. We investigated the prevalence of kidney function impairment in a homogeneous cohort of white-European primary infertile men.
Study design, size, duration
In this corss-sectional study, complete clinical and laboratories data from a cohort of 557 consecutive men aged >18 years, presenting for primary infertility investigation were analyzed.
Participants/materials, setting, methods
Comorbidities (as scored with the Charlson Comorbidity Index (CCI)) were collected in each patient. Primary outcome was the presence of functional impairment of the kidney (defined as an estimated glomerular filtration rates <90 ml/min/1.73m², according to the Kidney Outcomes Quality Initiative). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) function was used for eGFR calculation. Logistic regression analyses tested the association between kidney function impairment and clinical and semen features.
Main results and the role of chance
Of 557, 51 (9.3%) patients depicted at least a mild loss of kidney function (eGFR<90 ml/min /1.73m²). Median [interquartile (IQR)] age was 38 (35–42) years for normal kidney function group vs. 41 (36–46.5) years for those with impaired renal function (p < 0.001). Those with impaired renal function had also a higher BMI [26.1 (24.4–27.8) vs. 24.9 (23.2–26.8); p = 0.002] and higher numbers of comorbidities [CCI≥ 1 in 11 (21.5%) vs. 40 (7.9%) patients (p < 0.001)]. Of note, they had more frequently history of hypertension [10 (19.6%) vs. 31 (6.1%), p = 0.001]. Groups did not differ in terms of hormonal and semen features. At logistic regression analysis, older age and CCI≥1 were associated with a higher risk of impaired eGFR (OR 1.06; 95%CI 1.01–1.11; p = 0.016 and OR 2.41; 95%CI 1.06–5.15; p = 0.028, respectively)(table). No association was found between sperm parameters and eGFR impairment (all p > 0.05), after accounting for age, CCI, BMI, FSH, testicular volume, and varicocele.
Limitations, reasons for caution
Mild kidney function impairment characteristics were found in 9% of asymptomatic and unaware patients presenting for primary infertility investigation. Age and the rate of comorbidities are associated with reduced eGFR. Wider implications of the findings: This novel finding confirms growing data on a significant association of male infertility with a poorer overall male health status.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- G Fallara
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - L Boeri
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - L Candela
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - E Pozzi
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - F Belladelli
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - P Capogrosso
- ASST Sette Laghi – Circolo e Fondazione Macchi Hospital, Unit of Urology, Milan, Italy
| | - W Cazzaniga
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - E Ventimiglia
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - N Schifano
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - A Costa
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - D Cignoli
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - J Cornelius
- Luzerner Kantonsspital, Unit of Urology, Milan, Italy
| | - A Mattei
- Luzerner Kantonsspital, Unit of Urology, Milan, Italy
| | - F Montorsi
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| | - A Salonia
- San Raffaele Hospital, Division of Experimental Oncology/Unit of Urology, Milan, Italy
| |
Collapse
|
48
|
Pozzi E, Boeri L, Candela L, Cignoli D, Colandrea G, Raffo M, Cazzaniga W, Schifano N, Capogrosso P, Ventimiglia E, Abbate C, Montorsi F, Salonia A. O-207 Which infertile patients mostly deserve to have a sperm DNA fragmentation index done? Findings from a cross-sectional study. Hum Reprod 2021. [DOI: 10.1093/humrep/deab128.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
Current scientific guidelines do not clearly suggest which patients would benefit the most from a sperm DNA fragmentation (SDF) test.
Summary answer
We aimed to investigate potential predictive factors for altered SDF in a homogenous cohort of white-European men presenting for primary couple’s infertility.
What is known already
High SDF has been associated with reduced fertilization rates, reduced chances of natural conception and an increased risk of early pregnancy loss.
Study design, size, duration
Data from 478 consecutive men with normal or altered SDF were analysed. Infertility was defined according to the WHO criteria. Semen analysis, SDF (according to SCSA) and serum hormones were measured in every patient. Health significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Altered SDF was considered with a threshold of > 30%.
Participants/materials, setting, methods
Descriptive statistics compared the overall characteristics of patients with normal SDF and altered SDF. Logistic regression analysis tested potential predictors of altered SDF. ROC curve was used to test the accuracy of the model in predicting SDF alteration
Main results and the role of chance
Of 478 patients, 253 (57.7%) had altered SDF. Median (IQR) age and BMI of the whole cohort were 38 (35-42) years and 25.1 (23.3-27.1) kg/m2 respectively. Patients with altered SDF were older (median (IQR) age: 39 (36-43) vs. 37 (34-38) years, p < 0.0001), had lower sperm concentration (5 (1.1–18) vs. 17 x106/mL (6–38.8), p < 0.0001), testicular volume (15.1 (12 –20) vs. 16.8 (12 – 25) Prader, p = 0.0005), and total motile sperm count (TMSC) (1.8 (0.21–10.71) vs. 11.8x106 (2–37.26), p < 0.0001). Conversely, men with altered SDF had higher FSH (6.1 (3.85–9.7) vs. 4.8 (3.85 – 7.9) mIU/mL, p < 0.0001) and prolactin levels (9.8 (7.43–14.04) vs. 8.3 (6.6–11.3) pg/mL, p = 0.0004) than those with normal SDF. At multivariable logistic regression analysis, patients’ age >35 years (OR: 2.45, p = 0.0009), FSH > 8.0 mIU/mL (OR: 2.23, p < 0.0001) and lower TMSC (OR: 2.04, p = 0.002) were identified as indipendent predictors of altered SDF, after adjusting for testicular volume and CCI≥1. ROC curve (Figure 1) revealed that the model has a good predictive ability to identify patients with SDF alteration (AUC: 0.72, 95%CI: 0.67 - 0.77).
Limitations, reasons for caution
It is a retrospective analysis at a single, tertiary-referral academic centre, thus raising the possibility of selection biases. In spite of this, all patients have been consistently analysed over time with a rigorous follow-up, thus limiting potential heterogeneity in terms of data reporting
Wider implications of the findings
Primary infertile men older than 35 years, with high serum FSH and low TMSC at baseline are the ones who mostly deserve a SDF test over their diagnostic work-up and that would potentially benefit the most of certain treatments to improve SDF value, thus increasing chances of conceiving.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- E Pozzi
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - L Boeri
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - L Candela
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - D Cignoli
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - G Colandrea
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - M Raffo
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - W Cazzaniga
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - N Schifano
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - P Capogrosso
- ASST Sette Laghi – Circolo e Fondazione Macchi Hospital, Urology, Varese, Italy
| | - E Ventimiglia
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - C Abbate
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - F Montorsi
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| | - A Salonia
- Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology- URI-, Milano, Italy
| |
Collapse
|
49
|
Belladelli F, Pozzi E, Boeri L, Fallara G, Capogrosso P, Cignoli D, Candela L, Schifano N, Raffo M, Colandrea A, Montorsi F, Salonia A. P–027 Does air pollution impact on semen parameters? Findings from a real-life cross-sectional study in white-European infertile men. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
We aimed to investigate the association between air pollutants levels and semen parameters in a cohort of white-European men seeking medical attention for couple’s infertility.
Summary answer
We found that Pm10, Pm 2.5, and NO2 levels were negatively associated with sperm morphology.
What is known already
Air pollutants levels have been monitored closely for environmental and research issues in industrialized countries.
Study design, size, duration
Data from 156 infertile men consecutively assessed between 01/2019 and 12/2020 were analysed.
Participants/materials, setting, methods
Semen analyses were based on 2010 WHO reference criteria. We analysed the annual average level of the main markers of air pollution (Pm10, Pm2.5, and NO2) between 2014–2018 (Legambiente, 2020, Annual dossier series on air quality in Italy) relative to patients’ addresses of the last 5 years. Health-significant comorbidities were scored with the Charlson Comorbidity Index (CCI). Descriptive statistics and linear regression analyses were used to test the association between air pollutants and semen parameters.
Main results and the role of chance
Overall, median (IQR) age and BMI were 37 (33–41) years and 25.1 (23.4–27.3) kg/m2, respectively. A CCI≥1 was found in 12 (7.7%) men, and 47 (30.1%) participants were smokers. As for sperm parameters, semen volume, sperm concentration, sperm progressive motility and normal sperm morphology were 3 (2–4) ml, 18 (5–45.5) x106/ml, 32 (22–45)% and 2 (1–3)%, respectively. Pm10 was negatively associated with sperm morphology (ß: –0.580, p = 0.001). Furthermore, Pm10 was found to be an independent predictor for sperm morphology worsening (ß: –0.729, p = 0.006) (Fig.1A), after adjusting for age, BMI, CCI and smoking status. Similarly, Pm2.5 levels were negatively associated with sperm morphology (ß: –0.595, p = 0.009) (Fig.1B). After adjusting for the same variables, the association between Pm2 and sperm morphology remained significant (ß: –0.724, p = 0.015) (Fig.1C). NO2 levels were found to be associated with sperm morphology worsening after adjusting for age, BMI, CCI, and smoking status (ß: –0.471, p = 0.006).
Limitations, reasons for caution
It is a retrospective analysis at a single, tertiary-referral academic centre, thus raising the possibility of selection biases. Moreover, markers of air pollutions divided by residence may not completely evaluated the single patient exposure.
Wider implications of the findings: In this cross-sectional study we found that Pm10, Pm 2.5, and NO2 levels were negatively associated with sperm morphology, while they were not consistently associated with an increased risk of other abnormal sperm parameters in infertile men. Further studies are needed to characterize air pollution effects on sperm parameters.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- F Belladelli
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - E Pozzi
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - L Boeri
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - G Fallara
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - P Capogrosso
- ASST Sette Laghi – Circolo e Fondazione Macchi Hospital, Unit of Urology, Varese, Italy
| | - D Cignoli
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - L Candela
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - N Schifano
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - M Raffo
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - A Colandrea
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - F Montorsi
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| | - A Salonia
- IRCCS Ospedale San Raffaele, Division of Experimental Oncology/Unit of Urology, Milano, Italy
| |
Collapse
|
50
|
Pozzi E, Fallara G, Candela L, Costa A, Boeri L, Capogrosso P, Schifano N, Belladelli F, Cignoli D, Colandrea G, Raffo M, Cornelius J, Costantino A, Mattei A, Montorsi F, Salonia A. Primary organic vs. primary psychogenic erectile dysfunction: A cross-sectional study on patient’s characteristics and sexual function from a tertiary referral centre. Eur Urol 2021. [DOI: 10.1016/s0302-2838(21)00866-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|